Tracheobronchitis in the Intensive Care Unit

Tracheobronchitis can be broadly defined as inflammation of the airways between the larynx and the bronchioles. Clinically, this syndrome is recognized by an increase in the volume and purulence of the lower respiratory tract secretions and is frequently associated with signs of variable airflow obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, L., Schuller, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120547/
http://dx.doi.org/10.1007/978-3-540-34406-3_35
_version_ 1783514996762738688
author Morrow, L.
Schuller, D.
author_facet Morrow, L.
Schuller, D.
author_sort Morrow, L.
collection PubMed
description Tracheobronchitis can be broadly defined as inflammation of the airways between the larynx and the bronchioles. Clinically, this syndrome is recognized by an increase in the volume and purulence of the lower respiratory tract secretions and is frequently associated with signs of variable airflow obstruction. In the intensive care unit (ICU), tracheobronchitis is a relatively common problem with an incidence as high as 10.6% [1]. Although tracheobronchitis is associated with a significantly longer length of ICU stay and a prolonged need for mechanical ventilation, it has not been shown to increase mortality. These outcomes can be improved through the use of antimicrobial agents [1].
format Online
Article
Text
id pubmed-7120547
institution National Center for Biotechnology Information
language English
publishDate 2010
record_format MEDLINE/PubMed
spelling pubmed-71205472020-04-06 Tracheobronchitis in the Intensive Care Unit Morrow, L. Schuller, D. Infectious Diseases in Critical Care Article Tracheobronchitis can be broadly defined as inflammation of the airways between the larynx and the bronchioles. Clinically, this syndrome is recognized by an increase in the volume and purulence of the lower respiratory tract secretions and is frequently associated with signs of variable airflow obstruction. In the intensive care unit (ICU), tracheobronchitis is a relatively common problem with an incidence as high as 10.6% [1]. Although tracheobronchitis is associated with a significantly longer length of ICU stay and a prolonged need for mechanical ventilation, it has not been shown to increase mortality. These outcomes can be improved through the use of antimicrobial agents [1]. 2010-05-20 /pmc/articles/PMC7120547/ http://dx.doi.org/10.1007/978-3-540-34406-3_35 Text en © Springer-Verlag Berlin Heidelberg 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Morrow, L.
Schuller, D.
Tracheobronchitis in the Intensive Care Unit
title Tracheobronchitis in the Intensive Care Unit
title_full Tracheobronchitis in the Intensive Care Unit
title_fullStr Tracheobronchitis in the Intensive Care Unit
title_full_unstemmed Tracheobronchitis in the Intensive Care Unit
title_short Tracheobronchitis in the Intensive Care Unit
title_sort tracheobronchitis in the intensive care unit
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120547/
http://dx.doi.org/10.1007/978-3-540-34406-3_35
work_keys_str_mv AT morrowl tracheobronchitisintheintensivecareunit
AT schullerd tracheobronchitisintheintensivecareunit

Ejemplares similares